Pioglitazone improves virological response to peginterferon alpha-2b/ribavirin combination therapy in hepatitis C genotype 4 patients with insulin resistance (Q42992778)

From Wikidata
Jump to navigation Jump to search
scientific article published on 16 November 2009
edit
Language Label Description Also known as
English
Pioglitazone improves virological response to peginterferon alpha-2b/ribavirin combination therapy in hepatitis C genotype 4 patients with insulin resistance
scientific article published on 16 November 2009

    Statements

    Pioglitazone improves virological response to peginterferon alpha-2b/ribavirin combination therapy in hepatitis C genotype 4 patients with insulin resistance (English)
    Mahmoud Khattab
    Mohammed Emad
    Asharf Abdelaleem
    Rabab Atef
    Yehia Shaker
    Lamia Hamdy
    16 November 2009
    447-454

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit